Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole. - Test2 - elhamkhani - TriplyDB

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.

http://www.wikidata.org/entity/Q33214954

about

Bench-to-bedside review: Clostridium difficile colitis Detection of Clostridium difficile toxin: comparison of enzyme immunoassay results with results obtained by cytotoxicity assay Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection Antimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile Infection Predictors of Clostridium difficile colitis infections in hospitals Metabolism of bile salts in mice influences spore germination in Clostridium difficile The changing epidemiology of Clostridium difficile infections The challenges posed by reemerging Clostridium difficile infection.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.Clostridium difficile infection: Updates in management.[Clostridium difficile infections in geriatric patients].Antibiotic Regimen after a Total Abdominal Colectomy with Ileostomy for Fulminant Clostridium difficile Colitis: A Multi-Institutional Study.Probiotics for Clostridium difficile infection in adults (PICO): Study protocol for a double-blind, randomized controlled trial Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials.A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide.Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcome Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study.Use of International Classification of Diseases, Ninth Revision, Clinical Modification codes and medication use data to identify nosocomial Clostridium difficile infection.Ulcerative colitis worsened after Clostridium difficile infection: efficacy of infliximab.Fecal Microbiota Transplantation: From Clostridium difficile to Inflammatory Bowel Disease.Recovery of the gut microbiome following fecal microbiota transplantation.Clostridium difficile infection in patients with inflammatory bowel disease The potential value of Clostridium difficile vaccine: an economic computer simulation model.Clostridium difficile Infections: What Every Clinician Should Know Lack of association of outcomes with treatment duration and microbiologic susceptibility data in Clostridium difficile infections in a non-NAP1/BI/027 setting.Risk Factors for Treatment Failure and Recurrence after Metronidazole Treatment for Clostridium difficile-associated Diarrhea.Clostridium difficile infection in the inflammatory bowel disease patient.Colitis due to Clostridium difficile toxins: underdiagnosed, highly virulent, and nosocomial.Clostridium difficile colitis: a review.Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies.Synthetic polymers active against Clostridium difficile vegetative cell growth and spore outgrowth Rifaximin therapy for metronidazole-unresponsive Clostridium difficile infection: a prospective pilot trial.Strategies to prevent Clostridium difficile infections in acute care hospitals: 2014 Update.Long-Term Clinical Outcome of Clostridium difficile Infection in Hospitalized Patients: A Single Center Study A time-series analysis of clostridium difficile and its seasonal association with influenza.Characterization of a stable, metronidazole-resistant Clostridium difficile clinical isolate Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series.A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity.

P2860

Q24644191-C3F1FEFC-4A81-42F7-A25D-39C1C959A576 Q24676310-F7B963B4-7D8D-44BE-96A4-9AF0512D7250 Q26767079-EA76E14D-C4B5-41CF-857D-D78AD6AAC147 Q28084026-FCE5125C-61D2-4A2D-ABB4-989AB76B95B9 Q28395557-F4119DBF-BEA8-48AC-BD35-A3FAF3AE42DE Q28472543-9C8D56AF-95D8-414B-81E5-83E1DA3968B1 Q28750385-478BF5B9-094F-4B67-9A11-A77BFA41FD39 Q30229530-04FE7C15-7209-4FA6-B561-0B8CB9671782 Q30238945-23B61E7D-F40E-4054-ACB7-337793CDD380 Q30239988-3756DB89-DADA-4159-A12B-0AE1F87D76AF Q30244040-4F862ED0-A551-4A46-A587-573954F6BDDD Q30279196-5DC1DF63-E029-4DD3-8765-E0C44CD9F843 Q30354419-B03087F6-BC9F-446A-AC3B-89987204CF9A Q30417830-398A945D-A31D-48E7-8AAA-F6765E23909E Q30425705-33B278F5-4BCF-418E-AFB2-D984B5DD44B5 Q30437722-A26268F8-8362-4E72-BF74-1D7F51676FC4 Q33276804-506FECDF-BFD8-4FD9-A8AB-9A95A7A9AA03 Q33285304-0E30F284-D2A8-4ED2-8B91-315893040DF8 Q33398747-6B6B3AB7-72A1-4B62-9B2E-4A3B6E3C39D8 Q33508665-8BE6FF87-69DD-4B31-ADDE-965E0E164F90 Q33564263-A5FA3B17-E9A1-486E-BB87-56C6C813C67B Q33717111-51F3B922-B836-4D0A-9D2E-E0669327C623 Q33797312-7ADB33E8-958C-47AE-9138-4CAFD7ED47BC Q33947432-81E31866-BE29-49DE-A3EE-7BCFF892ECE9 Q34012314-8C8365B7-B0C8-47E7-BD6E-CB9F1AEFFE30 Q34028301-A3EA6F12-AB55-4EE4-B70E-172216CC8DB1 Q34072892-71B46837-6351-412F-BF11-AAF8E48FD983 Q34206660-00A02E01-C38B-402D-A07F-8FE3FDFA292D Q34234668-3EE1FE83-CC32-4505-9070-FBF46E06DDE8 Q34249194-8AFB121F-FD99-49C1-A9B4-8EFB7F38CD10 Q34260389-9F003D90-EFEE-4E4B-AA52-F2704238202B Q34306091-DDFACDE0-4BE0-4D49-95C5-3C7D6F31B0EF Q34408053-17A7E341-F7DE-4FD7-ACBD-F98331EA6349 Q34409185-523C61E3-AB6D-4DDB-B8F8-C314C66DE765 Q34419009-3511B079-5254-40D7-8AC2-272576648BA7 Q34429629-5EA82F62-D3D4-44BA-9ABA-0C563CFF20D9 Q34509883-D8068413-080A-4D4B-9FD1-96932E1447D8 Q34562315-DB08DBC5-10A7-4241-967B-1B0D3D405187 Q34611463-A52AB0B1-FE65-449C-AF16-47CDA70AA464 Q34643123-9241AB19-F6E9-4CE6-BD50-6541230D0398

P2860

Relatively poor outcome after treatment of Clostridium difficile colitis with metronidazole.

http://www.wikidata.org/entity/Q33214954

description

2005 nî lūn-bûn

@nan

2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Relatively poor outcome after ...... le colitis with metronidazole.

@ast

Relatively poor outcome after ...... le colitis with metronidazole.

@en

type

label

Relatively poor outcome after ...... le colitis with metronidazole.

@ast

Relatively poor outcome after ...... le colitis with metronidazole.

@en

prefLabel

Relatively poor outcome after ...... le colitis with metronidazole.

@ast

Relatively poor outcome after ...... le colitis with metronidazole.

@en

P1433

Q33214954-339C695F-1020-4A8A-AAE5-85AEED72ADB2

P1476

Q33214954-C970A7DE-4B9D-4447-8826-83A4A487C421

P2093

Q33214954-016922BC-EA41-490C-A4B9-B162B781463F

Q33214954-2AB8B55D-398C-488C-848D-9E788B4BEFD6

Q33214954-6771130F-A94C-40F8-A7D2-F66AE503C0AA

Q33214954-6E09C687-64B4-44D2-ACEF-91254A3CBF4F

Q33214954-AD7F9D9B-3640-4AFC-BDDC-C4E795A91F4A

Q33214954-C8D9A53C-2D71-4AC5-AACF-1314F30EAA17

Q33214954-EC6D8A68-EDE0-44CD-A316-F2CB0A4F6D43

P2860

Q33214954-0AB89E04-31F6-4F48-A5A6-E9FA8896D31B

Q33214954-14E97BE4-43F6-498E-8AEC-B8A51B580A8E

Q33214954-15F95509-A270-46EC-BCAE-C97BB36F999A

Q33214954-2F9CEB02-875C-4F95-B0E3-F633F7C81009

Q33214954-342E63B9-B387-4231-879A-ACDE35D11D11

Q33214954-3B69DCF3-6627-46DA-B82B-B956704B0DF1

Q33214954-4CF8B469-A643-4CAF-8344-EB2E04DA22BE

Q33214954-4D785273-9A0B-4BF9-ADF2-6770CABBF6DA

Q33214954-5FFC5A3B-2683-4EDE-99D2-A75E87541D7F

Q33214954-779224A4-D19C-4343-A17F-57D3DB5F0298

P304

Q33214954-16431D37-A170-4833-8057-DF8269DCAFCD

P31

Q33214954-C7F15367-C27D-41C7-8002-64C9A35FFEE7

P356

Q33214954-BE84FA4C-E7D3-42F9-9A2E-67B8CF0556B2

P407

Q33214954-56BCC60B-E9C9-42B5-AD62-172A352ACA92

P433

Q33214954-5CDDB175-73FE-4D56-B01F-F4FFE0AD7561

P478

Q33214954-C429421E-8C28-4A53-A97C-3736421447DE

P577

Q33214954-D9ABFB10-6975-4D32-9F96-A4D33919EA7E

P5875

Q33214954-95A35943-FA25-4C9D-A849-E9E88214091F

P698

Q33214954-484123F6-7C23-4DE9-AACF-51926A96CF15

P921

Q33214954-943551B9-0101-42B2-B354-5FA0C5C1884B

P356

P1433

Clinical Infectious Diseases

P1476

Relatively poor outcome after ...... le colitis with metronidazole.

@en

P2093

Daniel M Musher

http://www.w3.org/2001/XMLSchema#string

Franziska Borchert

http://www.w3.org/2001/XMLSchema#string

Imran Bhaila

http://www.w3.org/2001/XMLSchema#string

Nancy Logan

http://www.w3.org/2001/XMLSchema#string

Richard J Hamill

http://www.w3.org/2001/XMLSchema#string

Saima Aslam

http://www.w3.org/2001/XMLSchema#string

Srikanth Nallacheru

http://www.w3.org/2001/XMLSchema#string

P2860

Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A.

Clostridium difficile--Associated diarrhea: A review.

Fluoroquinolone use and Clostridium difficile-associated diarrhea.

Prospective randomised trial of metronidazole versus vancomycin for Clostridium-difficile-associated diarrhoea and colitis.

Clinical practice. Antibiotic-associated diarrhea.

Clostridium difficile vaccine and serum immunoglobulin G antibody response to toxin A

Outbreak of Clostridium difficile infection in a long-term care facility: association with gatifloxacin use.

Long-term surveillance of cefotaxime and piperacillin-tazobactam prescribing and incidence of Clostridium difficile diarrhoea.

Clostridium difficile-associated diarrhea in adults

Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity.

P304

1586-1590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/430311

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2005-04-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7852643

http://www.w3.org/2001/XMLSchema#string

P698

15889354

http://www.w3.org/2001/XMLSchema#string

P921

Clostridium difficile